probenecid has been researched along with Paranasal Sinus Diseases in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Paranasal Sinus Diseases: Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.
Excerpt | Relevance | Reference |
---|---|---|
"Actinomycosis is a rare anaerobic bacterial infection typically caused by Actinomyces israelii." | 2.49 | Invasive sinonasal actinomycosis: case report and literature review. ( Day, C; Suh, JD; Vorasubin, N; Wu, AW, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vorasubin, N | 1 |
Wu, AW | 1 |
Day, C | 1 |
Suh, JD | 1 |
1 review available for probenecid and Paranasal Sinus Diseases
Article | Year |
---|---|
Invasive sinonasal actinomycosis: case report and literature review.
Topics: Actinomycosis; Adjuvants, Pharmaceutic; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacteria | 2013 |